The Cell & Gene Meeting on the Mediterranean (“Meeting on the Med”) is a leading international conference focused on the advanced therapies sector, particularly cell and gene therapies. Organized by the Alliance for Regenerative Medicine, the event brings together biotechnology and pharmaceutical executives, researchers, investors, regulators, and other industry stakeholders from Europe and around the world to discuss the development and commercialization of advanced therapy medicinal products (ATMPs). The conference features expert-led panels, company presentations, and extensive networking and one-on-one partnering meetings. Key topics include regulatory issues, market access, manufacturing challenges, financing strategies, and emerging innovations in areas such as gene therapy, CAR-T, and regenerative medicine, with dozens of companies presenting their latest progress and partnerships.

https://meetingonthemed.com/

Date: April 28-30, 2026
Location: Rome Cavalieri, Rome, Italy

JOIN US!

We deliver fully integrated solutions across plasmids, viral vectors, autologous and allogeneic cell therapies, and iPSCs. Meet our Cell & Gene Therapy team to explore how our phase-appropriate approach can advance your program with confidence.

Complete the form to schedule a meeting with our experts!

SPEAKING ENGAGEMENTS

Speaking Engagement 1
Speaker: Philip Wills, Chief Commercial Officer, Catalent
Date/Time: Wednesday, April 29, 2026, 1:30 – 1:45 PM
Title: Enabling Patient Impact Through Strategic CDMO Partnerships

Speaking Engagement 2
Speaker: Frederic Cedrone, Vice President Corporate Innovation, Catalent
Date/Time: Tuesday, April 28, 2026, 5:15 – 6 PM
Title: AI-Driven Acceleration in Cell and Gene Therapy: From Discover to Delivery

ABOUT CATALENT

Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that Catalent helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. Catalent provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. Catalent tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matter™